User's Manual

Table Of Contents
10 Specifications
62
This device complies with Part 15 of the FCC Rules and RSS-210 of Industry Canada. Operation is
subject to the following two conditions: (1) this device may not cause harmful interference, and (2) this
device must accept any interference received, including interference that may cause undesired
operation. Any changes or modifications to this equipment not expressly approved by Philips Medical
Systems may cause harmful radio frequency interference and void your authority to operate this
equipment.
Devices Including the Short Range Radio Interface
Philips Medizin Systeme Boeblingen GmbH hereby declares that the radio component used
in this product is in compliance with the essential requirements and other relevant provisions of
Directive 1999/5/EC (Radio Equipment and Telecommunications Terminal Equipment Directive).
Class 1 radio equipment.
In addition the product complies with: ETSI EN 300 328; AS/NZS 4771+A1; ARIB STD-T66.
To obtain a copy of the original Declaration of Conformity, please contact Philips at the address as
stated in the "Manufacturer's Information" section of these Instructions for Use.
WARNING
This equipment generates, uses and radiates radio-frequency energy, and if it is not installed and
used in accordance with its accompanying documentation, may cause interference to radio
communications.
The device, equipped with a wireless network interface, intentionally receives RF electromagnetic
energy for the purpose of its operation. Therefore, other equipment may cause interference, even
if that other equipment complies with CISPR emission requirements.
IntelliVue 802.11 WLAN Adapter
FCC and Industry Canada Radio Compliance: This device complies with Part 15 of the FCC Rules and
RSS-210 of Industry Canada. Operation is subject to the following two conditions: (1) this device may
not cause harmful interference, and (2) this device must accept any interference received, including
interference that may cause undesired operation. Any changes or modifications to this equipment not
expressly approved by Philips Medical Systems may cause harmful radio frequency interference and
void your authority to operate this equipment.
The maximum antenna gain permitted (for devices in the 5250-5350 MHz and 5470-5725 MHz bands)
complies with the e.i.r.p. limits as stated in RSS-210.
The maximum antenna gain permitted (for devices in the 5725-5825 MHz band) complies with the
e.i.r.p. limits specified for point-to-point operation, as stated in RSS-210.
The device for the band 5150-5250 MHz is only for indoor usage to reduce potential for harmful
interference to co-channel mobile satellite systems.
The OEM radio device used in this product is in compliance with the essential requirements and other
relevant provisions of Directive 1999/5/EC. This product is intended to be connected to the Publicly
Available Interfaces (PAI) and used throughout the EEA.